SRTS — Sensus Healthcare, Inc
SRTS dilution and offerings
- Dilution risk: Low
- Float: 13.7M shares
🔔 Alert me if SRTS files an offering or S-3
$2.75-0.36%
Last close: · regular session
Last 59 sessions
Dilution risk: low. Float: 13.7M shares. Latest SEC filing: 10-Q on Aug 14, 2026. SRTS closed at $2.75 (-0.36%) on Nov 2, 2026.
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for SRTS in the TickerWise workspace.
Company profile
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
- Exchange: NASDAQ
- Employees: 60
- Website: https://www.sensushealthcare.com
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
Latest SEC filings for SRTS
Latest SRTS news
- At 4:30 p.m. Nov. 12, Sensus Healthcare will review financial results and take questions.
Related companies
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.